Supernus Pharmaceuticals Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Analysis

Supernus Pharmaceuticals, Inc. (SUPN)

50.70 -0.64 (-1.25%) USD | NASDAQ | Feb 12, 11:38

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) for SUPN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Benchmarks

Start Trial

Biogen, Inc.	Upgrade
Catalyst Pharmaceuticals, Inc.	Upgrade
Vertex Pharmaceuticals, Inc.	Upgrade
Krystal Biotech, Inc.	Upgrade
Moderna, Inc.	Upgrade